The hot topic of myopia control in the young is the basis of a scope of practice guidance document, released by the AOP.
The Association’s professional adviser, Geoff Roberson, told OT that recent media coverage, including on ITV, on the potential of myopia control treatments had prompted the release.
“We thought we ought to set out some sort of guidance for AOP members in view of a growing interest among the public,” he explained.
The document outlines that: “Given the increased long-term risks of eye disease that result from myopia, clinicians should certainly consider offering a safe evidence-based approach to managing the progression of myopia to school-aged children.”
However, Mr Roberson warned that while many international studies had seen significant and positive results from some interventions, there were still unanswered questions.
One thing that scientists did not yet understand was why some individuals were affected, while others were not, he highlighted.
“There isn’t an agreed clinical approach. A practitioner needs to think carefully about how they are going to approach this in an individual patient,” Mr Roberson explained.
The guidance emphasises the importance of managing expectations for a patient and their family, and of obtaining consent.
“The extent to which progression is reduced may be uncertain, unpredictable and ultimately disappointing to the patient in a situation where progression without intervention cannot be quantified,” the document warns.
To see the full guidance, visit the AOP website.
Image credit: Randen Pederson